首页> 中文期刊> 《中国医院用药评价与分析》 >临床药师参与1例支气管扩张并感染患者的药学实践

临床药师参与1例支气管扩张并感染患者的药学实践

         

摘要

OBJECTIVE:To explore the role of clinical pharmacist in clinical treatment for one patient with bronchiectasis com-plicating with infection. METHODS:The clinical pharmacist assisted clinician in making individualized treatment plan for the pa-tient based on the relevant guidelines for diagnosis and treatment of bronchiectasis and the results of etiological test,monitored the possible adverse drug reactions and provided rational pharmaceutical care and health education programs. RESULTS:Based on sus-ceptibility test result and patient’s renal function,clinical pharmacist made a dosage regimen of amikacin(0.3 g)plus ciprofloxa-cin(0.4 g)by ivgtt every 12 h which was adopted by clinicians and achieved good treatment effect. The patient was discharged in stable condition. CONCLUSIONS:Clinical pharmacist’involvement in clinical drug treatment practice can help improve clinical medical treatment level.%目的:探讨临床药师在1例支气管扩张并感染患者治疗中的作用。方法:临床药师协助医师,根据支气管扩张症诊疗相关指南及病原学结果为患者制订个体化治疗方案,关注患者在用药期间可能出现的不良反应,提供合理的药学服务和健康教育计划。结果:依据患者的药敏结果和肾功能情况,将给药方案调整为阿米卡星0.3 g、静脉滴注、q12h+环丙沙星0.4 g、静脉滴注、q12h,临床医师采纳了药师的建议,取得了良好的治疗效果,患者病情稳定出院。结论:临床药师参与临床药物治疗实践,有利于提高临床药物治疗水平。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号